Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name DT2216
Trade Name
Drug Descriptions

DT2216 is a small molecule proteolysis-targeted chimera (PROTAC) that binds to BCL-XL and targets it for degradation, potentially resulting in decreased tumor growth (PMID: 31792461, PMID: 32677976).

DrugClasses BCL-XL inhibitor 11


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Asparaginase + Dexamethasone + DT2216 + Vincristine Sulfate Asparaginase DT2216 Dexamethasone Vincristine Sulfate 1 0
Docetaxel + DT2216 DT2216 Docetaxel 1 0
Doxorubicin + DT2216 DT2216 Doxorubicin 1 0
DT2216 DT2216 1 0
DT2216 + S63845 DT2216 S63845 1 0
DT2216 + Venetoclax DT2216 Venetoclax 1 0
DT2216 + Vincristine Sulfate DT2216 Vincristine Sulfate 1 0

Additional content available in CKB BOOST